ACT logo

Enact Holdings (ACT) Stock

Profile

Country:

United States

IPO:

16 September 2021

Indexes:

Not included

Description:

ACT (Enact Holdings) is a company that provides insurance and risk management solutions. They focus on helping businesses manage their risks effectively, offering services like insurance underwriting and claims management. Their goal is to support clients in navigating challenges and ensuring financial stability.

Key Details

Price

$35.26

TTM Dividend Yield

2.03%(-57.35% YoY)

Annual Revenue

$1.15 B(+5.37% YoY)

Annual EPS

$4.11(-4.64% YoY)

PE Ratio

8.20(+17.99% YoY)

Beta

0.54

Events Calendar

Earnings

Next earnings date:

Feb 06, 2025

Recent quarterly earnings:

Nov 06, 2024

Recent annual earnings:

Feb 06, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Nov 18, 2024
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

05 Aug '24 BTIG
Buy
22 May '24 UBS
Neutral
04 Apr '24 Keefe, Bruyette & Woods
Outperform
03 Apr '24 JP Morgan
Neutral
06 Dec '23 UBS
Neutral
13 Nov '23 B of A Securities
Buy
03 Aug '23 Goldman Sachs
Neutral
09 May '23 B of A Securities
Neutral
05 May '23 Keefe, Bruyette & Woods
Outperform
05 May '23 Citigroup
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Aduro Clean Technologies Announces Closing of US$4 Million Uplisting to Nasdaq
Aduro Clean Technologies Announces Closing of US$4 Million Uplisting to Nasdaq
Aduro Clean Technologies Announces Closing of US$4 Million Uplisting to Nasdaq
ACT
globenewswire.com08 November 2024

LONDON, Ontario, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the closing of its underwritten U.S. public offering (the “Offering”) of 941,177 common shares at a public offering price of US$4.25 per common share. The common shares commenced trading on the Nasdaq Capital Market on November 7, 2024, under the ticker symbol “ADUR.

Enact Holdings, Inc. (ACT) Q3 2024 Earnings Call Transcript
Enact Holdings, Inc. (ACT) Q3 2024 Earnings Call Transcript
Enact Holdings, Inc. (ACT) Q3 2024 Earnings Call Transcript
ACT
seekingalpha.com08 November 2024

Enact Holdings, Inc. (NASDAQ:ACT ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Daniel Kohl - Vice President, Finance & Investor Relations Rohit Gupta - President & Chief Executive Officer Dean Mitchell - Chief Financial Officer & Treasurer Conference Call Participants Doug Harter - UBS Mihir Bhatia - Bank of America Bose George - KBW Richard Shane - JPMorgan Operator Good day and welcome to the Enact Third Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.

Why Enact Holdings (ACT) Could Beat Earnings Estimates Again
Why Enact Holdings (ACT) Could Beat Earnings Estimates Again
Why Enact Holdings (ACT) Could Beat Earnings Estimates Again
ACT
zacks.com10 October 2024

Enact Holdings (ACT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Strategist discusses ACT's raised $47 billion bid for 7-Eleven owner Seven & i
Strategist discusses ACT's raised $47 billion bid for 7-Eleven owner Seven & i
Strategist discusses ACT's raised $47 billion bid for 7-Eleven owner Seven & i
ACT
youtube.com10 October 2024

Nicholas Smith, Japan strategist at CLSA, says Seven & i's restructuring plans may be a case of "too little too late."

7-Eleven owner rejects $38bn takeover bid as it ‘grossly undervalues' business
7-Eleven owner rejects $38bn takeover bid as it ‘grossly undervalues' business
7-Eleven owner rejects $38bn takeover bid as it ‘grossly undervalues' business
ACT
proactiveinvestors.co.uk06 September 2024

7-Eleven's Japanese owner Seven & i has formally rejected a takeover bid tabled by Canadian convenience store giant Alimentation Couche-Tard Inc (TSX:ATD.B) (ACT). ACT, which owns the Circle K chain, announced the surprise $38 billion bid in August, in what would have been the largest takeover of a Japanese corporate in history.

PRIMO WATER AND BLUETRITON BRANDS ANNOUNCE EXPIRATION OF THE WAITING PERIOD UNDER THE HSR ACT
PRIMO WATER AND BLUETRITON BRANDS ANNOUNCE EXPIRATION OF THE WAITING PERIOD UNDER THE HSR ACT
PRIMO WATER AND BLUETRITON BRANDS ANNOUNCE EXPIRATION OF THE WAITING PERIOD UNDER THE HSR ACT
ACT
prnewswire.com05 September 2024

TAMPA, Fla. and STAMFORD, Conn.

Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines
Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines
Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines
ACT
globenewswire.com21 August 2024

RALEIGH, N.C., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today addressed the updated Private Mortgage Insurer Eligibility Requirements (PMIERs) released by Fannie Mae and Freddie Mac (the GSEs), and the Federal Housing Finance Administration (FHFA) on August 21, 2024 which will be phased-in between March 31, 2025 and September 30, 2026.

CSE Bulletin: Consolidation - Aduro Clean Technologies Inc. (ACT)
CSE Bulletin: Consolidation - Aduro Clean Technologies Inc. (ACT)
CSE Bulletin: Consolidation - Aduro Clean Technologies Inc. (ACT)
ACT
newsfilecorp.com19 August 2024

Toronto, Ontario--(Newsfile Corp. - Le 19 août/August 2024) - Aduro Clean Technologies Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every three and one quarter (3.25) pre-consolidated common shares. As a result, the outstanding shares of the company will be reduced to approximately 27,174,297 common shares.

Actinium Expands Patent Coverage Over Iomab-ACT, its Next-Generation Targeted Radiotherapy Conditioning Agent, for Gene Edited Stem Cell-Based Therapies for Non-Malignant Indications
Actinium Expands Patent Coverage Over Iomab-ACT, its Next-Generation Targeted Radiotherapy Conditioning Agent, for Gene Edited Stem Cell-Based Therapies for Non-Malignant Indications
Actinium Expands Patent Coverage Over Iomab-ACT, its Next-Generation Targeted Radiotherapy Conditioning Agent, for Gene Edited Stem Cell-Based Therapies for Non-Malignant Indications
ACT
prnewswire.com01 August 2024

-       Newly issued U.S. patent augments Actinium's existing composition of matter patent coverage over Iomab-B and Iomab-ACT targeted radiotherapy conditioning programs -       Pertains to the use of Iomab-ACT with genetically engineered hematopoietic stem cells for treating non-malignant diseases including sickle cell disease, severe combined immunodeficiency disease, β-thalassemia and Fanconi's anemia NEW YORK , Aug. 1, 2024 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies, today announced the issuance of U.S. Patent No. 11,912,780 titled, "Anti-CD45-Based Conditioning Methods and Uses Thereof in Conjunction with Gene-Edited Cell Based Therapies" by the United States Patent and Trademark Office (USPTO).

Enact Holdings, Inc. (ACT) Surpasses Q2 Earnings Estimates
Enact Holdings, Inc. (ACT) Surpasses Q2 Earnings Estimates
Enact Holdings, Inc. (ACT) Surpasses Q2 Earnings Estimates
ACT
zacks.com31 July 2024

Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.10 per share a year ago.

FAQ

  • What is the primary business of Enact Holdings?
  • What is the ticker symbol for Enact Holdings?
  • Does Enact Holdings pay dividends?
  • What sector is Enact Holdings in?
  • What industry is Enact Holdings in?
  • What country is Enact Holdings based in?
  • When did Enact Holdings go public?
  • Is Enact Holdings in the S&P 500?
  • Is Enact Holdings in the NASDAQ 100?
  • Is Enact Holdings in the Dow Jones?
  • When was Enact Holdings's last earnings report?
  • When does Enact Holdings report earnings?
  • Should I buy Enact Holdings stock now?

What is the primary business of Enact Holdings?

ACT (Enact Holdings) is a company that provides insurance and risk management solutions. They focus on helping businesses manage their risks effectively, offering services like insurance underwriting and claims management. Their goal is to support clients in navigating challenges and ensuring financial stability.

What is the ticker symbol for Enact Holdings?

The ticker symbol for Enact Holdings is NASDAQ:ACT

Does Enact Holdings pay dividends?

Yes, Enact Holdings pays dividends. The last payment was $0.18, with an ex-dividend date on 18 November 2024

What sector is Enact Holdings in?

Enact Holdings is in the Financial Services sector

What industry is Enact Holdings in?

Enact Holdings is in the Insurance - Specialty industry

What country is Enact Holdings based in?

Enact Holdings is headquartered in United States

When did Enact Holdings go public?

Enact Holdings's initial public offering (IPO) was on 16 September 2021

Is Enact Holdings in the S&P 500?

No, Enact Holdings is not included in the S&P 500 index

Is Enact Holdings in the NASDAQ 100?

No, Enact Holdings is not included in the NASDAQ 100 index

Is Enact Holdings in the Dow Jones?

No, Enact Holdings is not included in the Dow Jones index

When was Enact Holdings's last earnings report?

Enact Holdings's most recent earnings report was on 6 November 2024

When does Enact Holdings report earnings?

The next expected earnings date for Enact Holdings is 6 February 2025

Should I buy Enact Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions